<p>The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi for 48 h on caspase-3, caspase-8, and caspase-9 activity levels in Caco-2 cells. Data are presented as the means ± SD from three independent experiments. <b><i><sup>*</sup></i></b>, <i>P</i> < 0.05 compared with CTR; <sup>†</sup>, <i>P</i> < 0.05 compared with shGal-3; <sup>‡</sup>, <i>P</i> < 0.05 compared with Epi; <sup>§</sup>, <i>P</i> < 0.05 compared with overGal-3.</p
<p>Immunoblot analysis of activated caspase-3 (<b>A</b>) and Bcl-2 family proteins (<b>B, C, D</b>) ...
The figure shows Caspase 3/7 activation (columns) and cell viability (lines) in HeLa, Caco-2 and COL...
<p>Proteins were run on SDS-PAGE and immunoblotted with anti-NFAT1, anti-p65 or anti-Foxp3 antibody ...
<p>The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi for 48 h on the...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, transfection with a galect...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi (1 µ...
<p>(<b>A</b>) Western blotting and (<b>B</b>) quantification results of Western blotting for galecti...
<p>Cells were pretreated with scrambled shRNA, shGal-3, and/or Epi for 3 h. (<b>A</b>) Three-dimensi...
<p>Cells were treated with medium, Epi, and/or shGal-3 for 48 h. (<b>A</b>) Cell apoptosis was then ...
<p>GSK-3β and Bax were upregulated after the treatment of galectin-3 knockdown cells. The expression...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
<p>The effect of EPO on caspase-3 activity was determined using caspase-3 colorimetric assay. H9C2 c...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
(A) AGS cells were incubated with or without LiCl (20 mM) or SB (25 μM) for 24 hours. Western blot a...
<p>Scrambled control and GRP78 knockdown DLD-1 cells were treated with epirubicin (500 ng/ml) for th...
<p>Immunoblot analysis of activated caspase-3 (<b>A</b>) and Bcl-2 family proteins (<b>B, C, D</b>) ...
The figure shows Caspase 3/7 activation (columns) and cell viability (lines) in HeLa, Caco-2 and COL...
<p>Proteins were run on SDS-PAGE and immunoblotted with anti-NFAT1, anti-p65 or anti-Foxp3 antibody ...
<p>The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi for 48 h on the...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, transfection with a galect...
<p>(<b>A</b>) The effect of treatment with CTR, scrambled shRNA, shGal-3, overGal-3, and/or Epi (1 µ...
<p>(<b>A</b>) Western blotting and (<b>B</b>) quantification results of Western blotting for galecti...
<p>Cells were pretreated with scrambled shRNA, shGal-3, and/or Epi for 3 h. (<b>A</b>) Three-dimensi...
<p>Cells were treated with medium, Epi, and/or shGal-3 for 48 h. (<b>A</b>) Cell apoptosis was then ...
<p>GSK-3β and Bax were upregulated after the treatment of galectin-3 knockdown cells. The expression...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
<p>The effect of EPO on caspase-3 activity was determined using caspase-3 colorimetric assay. H9C2 c...
Multidrug resistance (MDR), an unfavorable factor compromising the treatment efficacy of anticancer ...
(A) AGS cells were incubated with or without LiCl (20 mM) or SB (25 μM) for 24 hours. Western blot a...
<p>Scrambled control and GRP78 knockdown DLD-1 cells were treated with epirubicin (500 ng/ml) for th...
<p>Immunoblot analysis of activated caspase-3 (<b>A</b>) and Bcl-2 family proteins (<b>B, C, D</b>) ...
The figure shows Caspase 3/7 activation (columns) and cell viability (lines) in HeLa, Caco-2 and COL...
<p>Proteins were run on SDS-PAGE and immunoblotted with anti-NFAT1, anti-p65 or anti-Foxp3 antibody ...